1 completed, 1 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
Follow Nicholas Gulati: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Diphencyprone Plus Immune Checkpoint Inhibition in the Treatment of Cutaneous Metastases Diphencyprone (DPCP) - Cutaneous Metastases | Phase 1 | Recruiting | Nicholas Gulati | 100 | 2022-10-06 | 2026-02-10 |
| DPCP to Treat Cutaneous Neurofibromas Associated With NF1 DPCP - Cutaneous Neurofibroma | Phase 1 | Completed | Nicholas Gulati | 17 | 2022-09-14 | 2024-05-06 |
Neurofibromatoses (1) · Neurofibromatosis 1 (1)
United States (2)
Philip Friedlander, MD, PhD (1) · Rebecca Brown, MD, PhD (1)